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Nanoparticles are widely used as carrier materials for biomedical applications such as 
functional and morphological imaging diagnosis and therapeutic drug delivery1. Based on their 
performance in these biomedical applications, nanoparticles have attracted great interest as a 
platform for combining diagnostics and therapy. Research efforts are currently underway to 
design effective theranostic nanoparticles that enable imaging diagnosis and therapy 
simultaneously. Liposomes, which have been used clinically for drug delivery systems, are a 
principal platform for theranostic applications.2 
Specifically gold nanoparticles (AuNPs) are emerging as promising agents for cancer therapy 
and are being investigated as drug carriers, photothermal agents, contrast agents and 
radiosensitizers. 3 The use of NPs as radiosensitizers is also related to nanoparticle enhanced X-
ray therapy or NEXT.4 They are very inert and highly biocompatible; they induce the radiation 
effect over a large tumor area; they are well absorbed into the systemic circulation; they have 
low systemic clearance, which allows enough time for photosensitizing material to be absorbed 
into the tumor tissue, and lower clearance rates also result in an enhanced permeability and 
retention (EPR) effect; and they can be designed in different sizes or shapes (such as cubes, 
spheres, cones or rods), to optimize their delivery to get the best results.5 
Another type of nanoparticles with a clear prospect of being approved in the clinic are magnetic 
nanoparticles (made up of metals such as iron). These nanoparticles are used in hyperthermia 
protocols, in which an alternating magnetic field is used to heat the nanoparticles. Thus, they 
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On the other hand, liposomes, the vesicles of phospholipid bilayer, can encapsulate both 
hydrophilic and lipophilic drugs and protect them from degradation. Liposomes have been 
extensively studied and continue to create intense interest in research since their discovery in 
the mid-1960s. Since then, liposomes have been considered to be the most successful 
nanocarriers for drug deliver and have made their way to the market. Currently, a number of 
liposomal formulations are on the marker for cancer treatment and many more are in pipe 
line.6 
Concretely magnetic liposomes offer opportunities as theranostic systems. The prerequisite for 
efficient imaging, tissue targeting or hyperthermia is high magnetic load of these vesicles. Here 
we describe the preparation of Ultra Magnetic Liposomes (UMLs), which may encapsulate iron 
oxide nanoparticles in a volume fraction of up to 30%. This remarkable magnetic charge 
provides UMLs with high magnetic mobilities, MRI relaxivities, and heating capacities for 
magnetic hyperthermia. Moreover, these UMLs are rapidly and efficiently internalized by 
cultured tumor cells and, when they are administered to mice, they can be vectorized to 
tumors by an external magnet.7 
The coupling of the ultra-magnetic liposomes with the gold nanoparticles permits us to 
combine the properties of both particles in radiotherapy to reduce non-specific side effects and 
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 1.1 Liposomes 
 
Liposomes, sphere-shaped vesicles consisting of one or more phospholipid bilayers, were first 
described in the mid-60s8. Liposomes are small artificial vesicles of spherical shape that can be 
created from cholesterol and natural non-toxic phospholipids. Due to their size and 
hydrophobic and hydrophilic character (besides biocompatibility), liposomes are promising 
systems for drug delivery. It has been displayed that phospholipids impulsively form closed 
structures when they are hydrated in aqueous solutions. Such vesicles which have one or more 
phospholipid bilayer membranes can transport aqueous or lipid drugs, depending on the nature 
of those drugs.  
The strategy followed by this project is to prepare Ultra Magnetic Liposomes (UMLs), suitable 
for systemic delivery characterized by an outstanding loading potential for magnetic 
nanoparticles. A high amount of MNPs in liposomes is critical for efficient MRI detection, 
magnetic targeting and heating of the sites of interest while minimizing the injected dose.7 
 
Liposomes are vesicles constituted by a concentric phospholipid bilayer (Figure 1), which 










                                                          
8
 Akbarzadeh, Abolfazl et al. “Liposome: Classification, Preparation, and Applications.” Nanoscale Research 
Letters 8.1 (2013): 102.  
9
 Cukierman E, Khan DR. The benefits  and challenges associated with the use of drug delivery systems in cancer 




Due to its larger size, when compared to most particles, liposomes can carry larger amounts of 
drugs. 
 
The organisation of this system is based on the presence of water, since the orientation of the 
bilayer may be determined by the nature of the polar groups and carbon/alkyl chains. 
 
The amphipathic nature of liposomes allows transportation of hydrophobic compounds 
interacting with the carbon/alkyl chains of their phospholipids and also of hydrophilic 
molecules in the interior aqueous cavity. The maintenance of the drug inside the liposome is 
dependent on the concentration, chemical nature, electric charge of the phospholipid, ionic 
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The general objective of the work is divided in four specific objectives: 
 
 
1. The synthesis of magnetic liposomes made by the reverse-phase evaporation 
technique. 
 
2. The synthesis of gold nanoparticles 
 
3. The coupling between the magnetic liposomes and gold nanoparticles 
 
4. Characterization of magneto-plasmonic liposomes by fluorimetry, dynamic light 




3. Experimental Section 
 
3.1 Synthesis of LUMs 
 
The synthesis of magnetic liposomes is made by the reverse-phase evaporation technique.11 
This technique consists of the formation of reverse micelles after sonication of a mixture of an 
organic phase and an aqueous phase. This aqueous phase consists of an aqueous suspension of 
iron oxides nanoparticles prepared to be encapsulated and an organic phase composed of 
phospholipids solubilized in chloroform and diethyl ether. Then, an external coating of PEG 
molecules will be performed in order to help the stabilization of the liposomes. Furthermore, 
an amine function (PEG-NH2) will be anchored, which will facilitate coupling with gold because 











Figure 2. Magnetic Liposome with a coating of PEG molecules. Red dots represent maghemite 
nanoparticles. 
 
The nanoparticles of maghemite (γ-Fe2O3) which were provided by the host laboratory were 
synthesized according to the Massart method12 by the aqueous mixture of ferrous and ferric 
solution in the form of hydrated chloride salts in alkaline medium. These nanoparticles had a 
size of 7 nm and they were dispersed in a buffer solution of HEPES, sodium chloride and water. 
They are concentrated in iron oxide  to 1 mol / L. 
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The PEG-NH2 is a widely used phospholipids-polymer conjugate in drug delivery applications
13.  
The use of these phospholipids allows the formulation of liposomes which will be used as 
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Figure 3. Schematic diagram of phase-reverse evaporation method. 
 
LUMs were synthetized using two amounts of PEG-NH2: 40 µL and 60 µL. This permits us to 
compare the size and potential zeta of two types of liposomes. The amounts of 90 µL of DPPC, 
10 µL of DSPC and 40/60 µL of PEG-NH2 were taken using a micropipette and all three were 
inserted into a glass tube. They were dissolved by 3 mL of diethyl ether and 1 mL of chloroform 
were collected by syringe and added to the mixture. The function of chloroform is to solubilize 
lipids. Then 1 mL of MNPs dispersed in a buffer 0.108 M NaCl, 0.02M citrate and 0.01M HEPES, 
(pH=7,4) was introduced on the tube.  
Two phases were obtained (Figure 4). An organic phase which contains the solubilized 
phospholipids in the solvent and an aqueous phase containing the nanoparticles of iron oxides 







Figure 4. Tube containing the liposome preparation 
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The tube was put in the ultrasound bath for 20 minutes. During the sonication, the action of 
homogenizer produced a water-in-oil emulsion between the two phases. Phospholipids were 
organized in the form of reverse micelles surrounding the nanoparticles of maghemite. 
After 20 minutes, the solution was immediately transferred to a 50 mL round-bottom flask  
with the aim of preserving the emulsion and then it was placed on a rotary evaporator at a 
temperature of 28 ° C. The ether was evaporated at a pressure of 335 mbar and then 
chloroform at 119 mbar.  
Evaporation of the solvent allows reverse micelles to approach each other; they will aggregate 
and form a gel. When all the solvent has been evaporated, the gel phase becomes liquid and 
the liposomes are formed. This passage is crucial and difficult to observe, so it’s necessary to be 
very careful. 
The solution containing the liposomes was filtered through a 400 nm filter in a plastic vial. 10 
ml of buffer solution were added into the flask to recover a maximum amount of liposomes and 
the whole was filtered over 400 nm in the same vial. At the end, 10 ml of liposome solution was 
obtained. 
Purification of liposomes from non-encapsulated maghemite MNPs was performed by magnetic 
sorting using a strong magnet purchased from Calamit (Figure 5). Along the walls, there was a 
black and dense liquid. The supernatant was brown clear and the liposomes had adhered to the 
walls of the syringe (Figure 6).The repetition of three times of this operation allows to separate 
liposomes from the supernatant and recovered. 
 
                  .  





3.2 Synthesis of gold nanoparticles   
 
Gold nanoparticles of ~ 20 nm diameter were synthesised according to Frens et al15 method. 
This synthesis consists in chemical reduction of AuCl4
- at pH 6.3-6.5 by dissolved trisodium 
citrate Na3Ctr at 100°C. 100 mL of 1mM HAuCl4 containing 200 µl of 1M NaOH was prepared in 
a 250 mL flask equipped with a condenser. The solution was brought to boil while being stirred 
and then 38.8 mM Na3Ctr was rapidly added. In this synthesis Na3Ctr simultaneously acts as (i) 
reducing agent (driving the reduction of AuIII to Au0) (ii) capping agent (electrostatically 
stabilizing the AuNP colloidal solution), and (iii) pH mediator (modifying the reactivity of Au 
species involved in the reaction).16 After waiting 15 min of reaction, the reflux system was shut 
down and deionized water was added to the AuNp seed suspension and make up to 100 mL.  
Growth reaction was performed in a 100 mL Erlenmeyer flask.  An aliquot of seed suspension 
(Nseed= 6.54 x1012 particles per ml) and 227 µL of 44.7 mM HAuCl4·3H2O were added to the 
flask with water.  Subsequently, an aliquot of 176 µL of 38.8 mM Na3Ctr·2H2O was added to the 
flask under constant stirring. (Figure 7). 
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3.3 Synthesis of magneto-plasmonic liposomes (Coupling) 
 
Magneto-plasmonic liposomes were synthesized by performing a coupling between the 









Figure 8. Coupling between the magnetic liposomes and gold nanoparticles 
 
Gold nanoparticles being citrated, they have COO- ions on the surface. It will be able to realize a 
peptide coupling with the magnetic liposomes which contains NH2 functions on their surface. To 
achieve this coupling, it is necessary to use a coupling agent. It was used EDC (Figure 9). The 
carbodiimide is a crosslinker that activates carboxyl groups for spontaneous reaction with 







Figure 9. Molecule of EDC 
 
Coupling is carried out with liposomes synthesized with 60 µL of PEG-NH2 and also with 40 µL 
of PEG-NH2. 
The procedure was: 20 µL of magnetic liposomes were taken to the micro-pipette and inserted 
into a glass vial. 1 ml of buffer solution and 1 mL of gold nanoparticles were added together 






After two hours, the flask was recovered (Figure 10). Purification of liposomes was performed 
by magnetic sorting using a strong magnet purchased from Calamit (Figure11). This step 
enables the separation of the magneto-plasmonic liposomes gold nanoparticles have not been 
coupled. 
The next day, the liposomes coupled with gold nanoparticles were recovered. It was observed 
in the syringe, a good decantation. Along the walls, there was a dark brown liquid in small 
quantities. The supernatant was light orange or brown. 
 
 

















4. Characterisation of synthetized compounds 
 
4.1 Characterization of magnetic liposomes 
 
The principles of characterization techniques are summarized in the annex. 
For the characterization of magnetic liposomes a dosage of amine functions by fluorimetry was 
realised. The size of the liposomes was determined by dynamic light scattering (DLS) and zeta 
potential is measured.  
 
4.1.1 Dosage of amine functions by fluorimetry 
The amount of amine functions on the surface of liposomes was quantified. The method used 
was a fluorimetry. Unfortunately, an incorrect calibration curve made the results of this 
fluorimetric measurement not usable. Thus, the amine functions couldn’t be quantified. 
Despite of this, the sample preparation procedure is described now. 
The purpose of this method is to combine our liposomes to a fluorescent molecule and then 
measuring the fluorescence of the compound thus synthesized. As a fluorescent molecule is 











Figure 12. fluorescent molecule: 4 - Phenylspiro- [furan-2 (3H), 1-phthalan] -3,3'-dione (Fluram) 
 
 
For this technique, it is necessary to make a calibration curve. It’s used for this purpose a 
standard APTS (Figure 13), which is a molecule containing an amine function. To avoid that they 









Figure 13. Molecule of APTS 
 
Procedure 
APTS solution: APTS was removed from the vial, taking care not to introduce air. For this, a 
needle surmounted by a balloon flask filled with nitrogen was introduced into the septum. The 
APTS was drawn into a syringe and introduced into an Eppendorf. 0, 56 g of PTSA were taken in 
a beaker and supplemented with 10 ml of ethanol, until 7,91g. 
Standards APTS: 6 standards were prepared containing respectively 0 µL, 20 µL , 40  µL, 80 µL, 
140 µL and 200 µL solution of APTS and supplemented with 10 ml of ethanol, until 7,91g. 
Fluram solution: 5.6 mg of Fluram were removed under a hood, and introduced into a beaker 
filled with 100 ml of ethanol, until 79.1 g. 
Three samples of magnetic liposomes were provided. Each one contains 15 µL, 30 µL and 40 µL 
of PEG-NH2. 
Preparation of fluorescent samples: 20 µL of each standard of PTSA were removed, introduced 
into a glass bottle and supplemented with 5 ml of Fluram solution until 3,96g. Similarly, 40 mL 
of each sample magnetic liposomes were removed, introduced into a glass bottle and 
supplemented with 5 ml of Fluram solution until 3,96g. The fluorescent sample was stirred 
vigorously and placed in the dark. It is necessary to take into account the time difference 
between the preparation of the first fluorescent sample and the last because there will be a 













4.1.2 Dynamic Light Scattering (DLS) 
The size of the magnetic liposomes was measured before and after separation step. This 
technique is very sensitive to dust, so the tanks are kept in the sealed packaging. The 
instrument used was the Zetasizer Nano ZS from Malvern. Some settings were changed, 
including equilibration time which was set to 60 s and the temperature at 25 ° C. The chosen 
solvent was water, and in the material parameter, ‘ferrofluid’ was chosen. 
One drop of liposome solution was taken and diluted in the buffer solution which was prepared 
before. The measuring vessel was filled to 1/3 with reference to the legend on the device and 
the measurement was performed. Intensity curves were obtained according to size. 
From the curves obtained there is a particle size of about 18 nm that doesn’t change before and 
after sorting. This size corresponds probably to the maghemite particles. Before sorting (Figure 
14), the liposomes have a size of approximately 255 nm which is a coherent result. After sorting 
(Figure 15), the measure has probably been distorted by other environmental factors such as 
dust. It is also possible that both liposomes have merged and we get twice the size before the 
sorting step. 
 
Before sorting:  
 














































Figure 15. Curve representing the intensity as a function of the size after sorting 
 
4.1.3 Determining the zeta potential 
The zeta potential, which gives an indication of the surface charge of the vesicles or micelles, 
was also measured using the Zeta Nanosizer ZS. A special cuvette with electrodes was used for 
this measurement. (Figure 16). The folded capillary cell was completed in full and corked and 
the zeta potential of the liposomes after the sorting step was measured. 
A zeta potential of 23.1± 2 mV is obtained with pH 7.4. This value is coherent because the 
measured zeta potential corresponds to the amine functions, so it must be positive. On the 
other side, the value represents a medium- stability solution. It should be noted that a good 
stability is comprised for values between 40-50 mV. 
  
 
















LUM after sorting  
20 
 
4.2 Characterization of gold nanoparticles  
 
Gold nanoparticles are characterized by measuring the size by DLS and the zeta potential.       
UV-Visible spectroscopy is also used. 
 
4.2.1 Dynamic Light Scattering (DLS) 
The sample was diluted in water. Figure 17 shows the particle size distribution of AuNPs. Two 
size values are obtained of 21 nm and 91 nm. The presence of two distributions may be due to 
aggregation of AuNPs. The first peak corresponds to smallest gold nanoparticles while second 
pick is attributed to an aggregation of gold nanoparticles.  
 
 




4.2.2 Zeta potential 
After measuring zeta potential it was obtained an average charge of -33.2 ± 2 mV. This value is 
consistent. Indeed, the gold nanoparticles that were citrated, they have COO- ions that 
provides them a negative charge.  It was suggested that the emulsions with zeta potential 
values of −11 to −20 mV were close to the threshold of agglomeration, while the emulsions 
with zeta potential values of −41 to −50 mV had good stability. 
The significance of zeta potential is that its value can be related to the short- and long-term 
stability of emulsions. Emulsions with high zeta potential (negative or positive) are electrically 
stabilized while emulsions with low zeta potentials tend to coagulate or flocculate, possibly 
leading to poor physical stability. In general, when the zeta potential of an emulsion is high, the 






















Gold nanoparticles are characterised to possess surface plasmons. When they are excited by 
light at a given frequency, the free electrons of the nanoparticle oscillate collectively. This is the 
surface plasmon resonance. They can therefore be characterized by UV-visible spectroscopy. 
The UV-visible spectroscopy gives an indication of the size of the gold nanoparticles. Indeed, as 
the size of the nanoparticles increases, as the absorbance band will move towards the higher 
wavelengths. 
The measurement was made using a fibre optic spectrophotometer. The following spectrum 
was obtained (Figure 18). 
 
Figure 18. Curve UV-visible of gold nanoparticles 
For the gold nanoparticles, an absorbance band was observed at 518±12 nm. The absorbed 
light is green. So the observed light is the complementary colour of green that is pink (Figure 
19). This is consistent because the colour of the gold nanoparticle solution synthetized was 
pink. 
 






















4.3 Characterization of magneto-plasmonic liposomes 
 
We characterized by UV-visible the magneto-plasmonic liposomes synthesized with 60 µL and 
40 µL of PEG-NH2 after sorting. Then, the size of liposomes was also measured. 
4.3.1 Dynamic Light Scattering 
The samples were diluted in the buffer solution. 
On one side, with 60 ml of PEG-NH2 a size of 190 nm was obtained (Figure 20). A size of 21 nm 
is also distinguishable from the liposomes which correspond at maghemite particles that have 
probably been released from the liposome. 
On the other hand, with 40 µL of PEG-NH2, it was obtained a bit small size of 106 nm (Figure 
21). As in the previous graph, the presence of particles of maghemite is clearly observable in 
this case. 
In view of the results achieved, coupling with 60 µL of PEG-NH2 produced particles with a size 
about twice as large as with the coupling with 40 µL of PEG-NH2. 
 
 
























Figure 21. Curve DLS LUM-Au (40 µL PEG-NH2) 
 
4.3.2 Zeta potential 
After measuring zeta potential of both samples of liposomes, a value of 28.3±5 mV was 
obtained for liposomes avec 40 µL and a value of 15.2±3 mV was obtained for liposomes 
synthetized with 60 µL of PEG-NH2. These results indicate that the first one have a quite good 
stability compared with the second one. 
For particles that are small enough, a high zeta potential gives it stability, that is, the solution or 
dispersion will resist aggregation. When the potential is low, there is attraction between the 
particles, the repulsion is overcome and flocs are formed instead of dispersion. Therefore, high 
potential zeta colloids are electrically stabilized, while colloids with low zeta potentials tend to 
coagulate or flocculate. 
This can explained the result obtained after measuring the size of liposomes. The size of 
liposomes with 60 µL is approximately twice the liposomes with 40 µL. Taking into account that 
the stability of the first one is not very high, it’s possibly that flocs were formed during the 





























The samples were diluted in the buffer solution. The following curves were obtained. 
The UV-Vis spectrum was obtained for the two complexes LUM-Au with 40µL of PEG-NH2 
(Figure 22) and 60 µL of PEG-NH2 (Figure 23).  
The gold surface plasmon resonance band is present but it is moved to lower wavelengths 
(about 480 nm). This is probably due to the aggregation of gold nanoparticles in the salt 
content in the buffer solution. 
 
 
Figure 22. Curve UV-Vis LUM-In (60 µL PEG-NH2) 
 
 






























4.3.4 Transmission Electron Microscopy (TEM) 
Liposomes magneto-plasmonics synthesized with 40 µL of PEG-NH2 were observed using 
Transmission Electron Microscopy 
For sample preparation it was preceded as follows: magnetic liposomes coupled with gold were 
recovered and diluted in 1 ml of buffer solution. Then 20 µL of the liposome solution were 
diluted again in the buffer solution until obtaining a light colour (Figure 24). One drop of the 
diluted solution was twice deposited on the microscope grid covered with a dried inert carbon 
layer. After the drop had dried, microscopy grid was placed in a Petri dish (Figure 25). 
 
      
Figure 24 Sample preparation                                Figure 25. Preparation of samples microscopy grids in a Petri dish   
 
The principle of this technique is detailed in the annexe. 
 
In the Figure 26 we can observe aggregated gold nanoparticles in a black intense which are 
more distinguishable. In the Figure 27 we can also see little particles less coloured which 
correspond to maghemite nanoparticles. There is also a significant salt layer from the buffer 
causing the aggregation of the nanoparticles of oxides of iron and gold which appear in Figure 
28. The last image, Figure 29 shows magneto-plasmonic liposomes, clearly distinguishable by 
his spherical shape containing maghemite nanoparticles and gold nanoparticles. This liposomes 










TEM gives the following micrographs (scale 20 nm): 
 
 









   Figure 27. Gold and iron oxide 
 
               















   




























5. Discussion and conclusion 
 
 In view of the results obtained it can be said that the synthesis has evolved in a satisfactory 
manner.  
We used quite sensitive techniques such as DLS, which may explain some imprecise results. 
The synthesis of gold nanoparticles was developed successfully obtaining a size of about 21 nm 
and a potential zeta consistent with their structure. 
Furthermore, by the reason that liposomes are very fragile, the synthesis is complicated and 
should be performed with great care. This explained that liposomes coupling with 60 µL 
weren’t observed in TEM. In addition, the low zeta potential of these liposomes shows the little 
stability of them.  
Finally, a size of ~100 nm of magneto-plasmonic liposomes was obtained, with a value of zeta 
potential which shows a not very high stability. Despite of this, the spherical vesicles were 
observed with TEM, clearly distinguishable from the other particles in the sample. The reason 
why size of liposomes has decreased during the synthesis may probably due to a reorganization 
of the phospholipids, producing smaller liposomes containing both gold and maghemite 
nanoparticles. Further studies are necessary to understand the parameters influencing the 
stability of the liposomes in order to get efficient magneto-plasmonic liposomes. 
After the synthesis, it would be necessary to see how the properties of these liposomes can be 
exploited in the medical field, particularly in theranostic applications, in favour of the relentless 
struggle against this terrible disease. 
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7.1 Characterization Techniques 
7.1.1 Fluorimetry 
Fluorimetry is an assay method using the property of some molecules to be fluorescent. It 
consists of measuring the fluorescence which is proportional to the concentration. 
A fluorescent molecule (either natural or obtained by formation of a derivative) has the 
property of absorbing light energy (excitation light) and quickly restores a portion of this 
absorbed light as fluorescent light (light of emission) at a higher wavelength. The molecule is 
excited by absorption of photons from the light source. The excitation results in a fluorescence 
radiation sent in all directions. The basic law of fluorimetry is that the intensity of the radiation 
emitted by fluorescence is proportional to the concentration of the molecule intercepting the 
light beam. 
7.1.2 DLS 
The dynamic light scattering (DLS) is an analytical technique spectroscopic non-destructive who 
allows to determine the size of the molecules. The analysis is based on the Brownian motion of 
the particles. It provides access to sizes of 1 to 500 nm. The sample to be analysed may be 
dispersed in various solvents. It is necessary to know the viscosity of the solvent and its 
refractive index. It works very middle diluted to avoid multicast and thus not analyse reissued 
makers. 
The laser beam illuminates the sample, the light is scattered in all directions at different 
intensities due to Brownian motion. The signal is collected on a detector placed at an angle 
theta with respect to the direction of the incident beam. (Figure 30) 
The sensor analyses the intensity fluctuations over time. A small particle because of the higher 
intensity fluctuations than large particle as it moves faster. By mathematical processing of these 
data by a correlator, a self-correlation as well as the diffusion coefficient is obtained D. 
Hydrodynamic diameter was determined using the Stokes-Einstein equation:   
    








7.1.3 Zeta potential 
 Zeta potential is the electric charge that a particle acquires through the cloud of ions that 
surround it when it is in suspension or in solution. Indeed, when she is moving in a liquid, she 
surrounds herself with ions organized in an "electric double layer": a portion of the ions clings 
to the particle thereby forming an ion layer adhering this dense layer. The other part of the ions 
forms an unbonded said diffuse layer. 
The "shear plane" defines these two layers (Figure 31). It’s the potential difference between the 
dispersion medium and the potential at the shear plane which defines the Zeta potential. This 
potential is a measure of the intensity of repulsion or electrostatic attraction between particles. 
Its measurement therefore provides an understanding of the causes of dispersion, aggregation 














Figure 31. Schema of electric double layer of a particle. 
 
Zeta potential of nanoparticles is relatively easy to measure. It provides extensive information 
on the properties and behaviour of nanomaterials in different environments: in vitro assays, 
soil, surface water ... The goal is to identify the properties that control the fate and effects of 
nanomaterials and eventually be able to predict the behaviour of a new nanomaterial based on 








Malvern Zetasizer Nano ZS equipment (Figure 32) can measure the size and zeta potential of 
nanoparticles. 
Such equipment makes it possible to measure sizes of 0.3 nm to 10 µm (diameter). 
 
Figure 32. ZetaSizer Malvern Nano ZS used to measure the size and zeta potential 
 
7.1.4 UV-Visible 
  The ultraviolet-visible spectroscopy is a spectroscopic technique involving photons whose 
wavelengths are in the ultraviolet range (200 nm - 400 nm), visible (400 nm - 750 nm) or near 
infrared (750 nm 1400 nm). Subjected to radiation in this range of wavelengths, molecules, ions 
or complexes may undergo one or more electronic transitions. The analysed substrates are 
















The electronic spectrum is the function which connects the light intensity absorbed by the 
sample analysed according to the wavelength. The spectrum is often presented as a function of 
absorbance depending on the wavelength. It can also be described as the molar extinction 
coefficient as a function of wavelength, then the spectrum is independent of the length solute 
concentration that absorbs. 
The technical analysis is often used in a quantitative method for determining the concentration 
of a chemical entity in solution, using the Beer-Lambert law: 
 
wherein I / I0 is the transmittance of the solution (no unit), A is the absorbance or optical 
density at a wavelength λ (unitless)ελ is the molar extinction coefficient (in L/mol·cm). 
 
 
7.1.5 Transmission Electron Microscopy (TEM) 
The principle of transmission electron microscopy is based on an electron beam extracted from 
a heating filament (or field effect) and accelerated by a high voltage (of the order of 50000-
3000000 V) to level of the barrel, which is focused by magnetic fields of the order of tesla.  
The beam of electrons can be treated either as particles or as waves. The physics of the 
formation of the image is similar to that of optical photonics. This is a first approximation, with 
the single tool like optical geometric that we can study the formation of the image by 
transmission electron microscopy. A schema of a transmission electron microscope is 











Figure 34. Scheme transmission electron microscope. 
